The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 27-year-old male with a single episode of psychosis 18 months ago was maintained on olanzapine 10 mg daily with full symptom resolution for 14 months. After shared decision-making, a gradual taper was initiated over eight weeks, and olanzapine was discontinued four weeks ago. He now presents with his mother, who reports he has become increasingly suspicious of neighbors, believes his phone is being monitored, and has been sleeping only 3-4 hours per night for the past week. His BPRS score is 42. He was adherent to the taper schedule and had no substance use during this period. The PMHNP is evaluating whether this represents a relapse of the underlying psychotic disorder or supersensitivity psychosis related to discontinuation. Which of the following best represents the appropriate evaluation?
Explanation
Differentiating supersensitivity psychosis from true relapse after antipsychotic discontinuation is clinically challenging and often cannot be resolved at the time of acute presentation. The priority is acute stabilization followed by systematic longitudinal data collection including response speed, duration, and recurrence patterns to inform future treatment decisions.
Key Takeaway
When psychotic symptoms emerge after antipsychotic discontinuation, the evaluation should acknowledge the diagnostic uncertainty between relapse and supersensitivity psychosis, prioritize acute stabilization, and document longitudinal markers to guide future treatment planning.